聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 50 分钟 57 秒 前

Adapt Pharma Names Mike Kelly President of U.S. Operations

周一, 04/11/2016 - 19:48
Contributing Over 25 Years of Pharmaceutical Expertise to Adapt Executive Team DUBLIN, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Adapt Pharma, (www.adaptpharma.com) announced today that Mike Kelly has been appointed as President of U....
Biopharmaceuticals, Personnel
Adapt Pharma, NARCAN, naloxone

Stryker Acquires SafeWire Product Portfolio for Use in Minimally-Invasive (MIS) Spine Procedures

周一, 04/11/2016 - 19:46
Technology Used with Stryker’s Percutaneous ES2 Spinal Fixation System & LITe (Less Invasive Technologies) Procedural Solutions ALLENDALE, N.J.--(Healthcare Sales & Marketing Network)--Stryker’s Spine division today announced the acquisition of the Safe...
Devices, Orthopaedic, Neurosurgery, Acquisitions
Stryker, SafeWire, Y-Wire, Tiger Jamshidi Needle

St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy

周一, 04/11/2016 - 14:43
Availability of the dorsal root ganglion (DRG) therapy represents an important milestone in the treatment of chronic intractable pain conditions due to complex regional pain syndrome I and II ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. ...
Devices, Neurology, Product Launch
St. Jude Medical, dorsal root ganglion, Axium , Neurostimulator, DRG therapy

Profound Medical Corp., receives CE Mark Approval for TULSA-PRO(TM)

周一, 04/11/2016 - 14:35
TORONTO, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Profound Medical Corp. (“Profound” or “Company”) (PRN.V), a medical device company commercializing a unique and minimally invasive therapy in prostate care, today announced that the compa...
Devices, Urology, Regulatory
Profound Medical, TULSA-PRO, prostate, ablation

GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex

周一, 04/11/2016 - 14:27
LONDON, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary ca...
Biopharmaceuticals, Neurology
GW Pharmaceuticals, Epidiolex, cannabidiol, Tuberous Sclerosis Complex

FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer

周一, 04/11/2016 - 12:49
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Applicat...
Biopharmaceuticals, Personalized Medicine, Oncology, FDA
Genentech, Roche Group, atezolizumab, NSCLC, Cancer Immunotherapy

Voluntary Recall of Fetch(TM) 2 Aspiration Catheter

周五, 04/08/2016 - 21:41
MARLBOROUGH, Mass., April 8, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) has initiated a global, voluntary recall of all models of its Fetch™ 2 Aspiration Catheter, a thrombectomy catheter used during procedures to remo...
Devices, Interventional, Cardiology, Product Recall
Boston Scientific, Fetch 2, Aspiration Catheter, thrombectomy

Avion Pharmaceuticals, LLC, announces appointment of new Chief Executive Officer

周五, 04/08/2016 - 15:09
ATLANTA, April 8, 2016 -- (Healthcare Sales & Marketing Network) -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, is pleased to announce the appointment of Harold A. Deas, Jr. as Chief Executive Officer. Mr. Deas, who will retain his rol...
Biopharmaceuticals, Dermatology, Personnel
Avion Pharmaceuticals

Eli Lilly and Company and AstraZeneca Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer's Disease

周五, 04/08/2016 - 15:06
Phase 2/3 trial of AZD3293, an oral potent small molecule BACE inhibitor, will continue to Phase 3 after positive interim safety data INDIANAPOLIS, April 8, 2016 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) and AstraZeneca t...
Biopharmaceuticals, Neurology
Eli Lilly, AstraZeneca, beta secretase cleaving enzyme, Alzheimer's

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong